section name header

Basics ⬇

DESCRIPTION navigator

EPIDEMIOLOGY navigator

Prevalence navigator

Prevalence depends on level of sickness of population and location where assessment is performed.

RISK FACTORS navigator

ETIOLOGY navigator

MAT usually occurs during critical illness, especially in the setting of chronic lung disease. #x03B2-Agonists and methylxanthine derivatives (theophylline) may be contributory.

COMMONLY ASSOCIATED CONDITIONS navigator

See above regarding Etiology.


Outline

Diagnosis ⬆ ⬇

Signs and symptoms:

DIAGNOSTIC TESTS & INTERPRETATION navigator

DIFFERENTIAL DIAGNOSIS navigator


Outline

Medication (Drugs) ⬆ ⬇

First Line

Electrical cardioversion is NOT helpful.

Treatment ⬆ ⬇

ADDITIONAL TREATMENT

General Measures navigator

IN-PATIENT CONSIDERATIONS

Admission Criteria navigator

Usually arrhythmia is 1st recognized in inpatients. Discharge is determined by resolution of other medical problems.


Outline

Ongoing Care ⬆ ⬇

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring navigator

PROGNOSIS navigator

Depends on underlying disease


Outline

Miscellaneous ⬆ ⬇

CODES

ICD9

427.89 Other, specified cardiac dysrhythmias

SNOMED

49982000 multifocal atrial tachycardia (disorder)

Reference(s) ⬆ ⬇

ADDITIONAL READING

SEE ALSO

Author(s) ⬆

Peter Ott

Andrew E. Epstein